Euractiv Est. 1min 25-11-2019 (updated: 06-01-2020 ) A number of EU countries are developing or have already put in place policies for granting patients easier access to medical marijuana after Germany led the way by passing a reform of the country's drugs law in 2017. [SHUTTERSTOCK] Euractiv is part of the Trust Project >>> Print Email Facebook X LinkedIn WhatsApp Telegram The medical cannabis industry is growing rapidly in Europe and thousands of patients are already prescribed with cannabis-based drugs. This created a new demand that now runs the risk of being unsatisfied if the legislation remains fragmented amongst EU countries. Several decision-makers and stakeholders are calling on the European Commission to investigate which kind of regulatory measures at the EU level should be put in place to meet patients’ needs. Standards, safety, ethics and sustainability are the topics to discuss further when it will be time to draft guidelines and pieces of regulation with the aim of creating a regulatory environment for patients and investors. Subscribe now to our newsletter EU Elections Decoded Email Address * Politics Newsletters Download PDF The European Medical Cannabis Association – the Brussels-based industry body – calls for harmonised EU regulatory framework to create equal access for patients Video | Promoted content | Health 12-12-2019 The European Medicinal Cannabis Association (EUMCA), the newly formed Brussels-based industry body, represents the interests of ethical companies working in the supply and manufacturer of medicinal cannabis. EU should adopt German standards on medical cannabis, campaigners say News | Health 29-11-2019 Est. 5minGermany's regulatory approach to medical cannabis is good practice and should be replicated across Europe, according to newly-born European Medicinal Cannabis Association (EUMCA). Governments are legalizing medical cannabis. Why is it so hard for patients to access? Opinion | Promoted content | Health 28-11-2019 Est. 7minPatients deserve faster access to safe medical cannabis. Legalization is not enough – governments and businesses need to work together to reduce barriers and lessen patients’ reliance on the illicit market. MEP: EU framework on medical cannabis to give ‘peace of mind’ to patients News | Health 25-11-2019 Est. 5minA strong EU regulatory framework on medical cannabis is needed to provide investors with stability but also to give peace of mind to patients struggling with fragmented legislation among member states, socialist MEP Miriam Dalli said.
